TODD STRATEGY GROUP

Lobbying for GENMAB · Biotech company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Medicare/Medicaid

General Medicare/Medicaid Issues. 340B Issues.

Health Issues

Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.